Lexeo Therapeutics (LXEO) EBITDA (2022 - 2026)
Lexeo Therapeutics (LXEO) posted EBITDA of -$27.95 million for Q2 2026, compared with -$30.63 million a year earlier.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) EBITDA (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Lexeo Therapeutics was -$94.82 million; for FY2025, it was -$108.99 million.
- In prior years, Lexeo Therapeutics' EBITDA was -$105.46 million in FY2024, -$68.24 million in FY2023 and -$60.39 million in FY2022.
- Quarterly EBITDA has run from a low of -$33.75 million in Q1 2025 to a high of -$13.92 million in Q2 2023 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$22.26 million (Q1 2026), -$23.04 million (Q4 2025) and -$21.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Lexeo Therapeutics | 248.75 Mn | -411.66 Mn | - | -27.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.87 Mn |
| Mar 31, 2026 | -22.18 Mn |
| Dec 31, 2025 | -22.96 Mn |
| Sep 30, 2025 | -21.50 Mn |
| Jun 30, 2025 | -30.55 Mn |
| Mar 31, 2025 | -33.67 Mn |
| Dec 31, 2024 | -27.23 Mn |
| Sep 30, 2024 | -31.38 Mn |
| Jun 30, 2024 | -23.39 Mn |
| Mar 31, 2024 | -23.14 Mn |
| Dec 31, 2023 | -14.82 Mn |
| Sep 30, 2023 | -20.12 Mn |
| Jun 30, 2023 | -13.84 Mn |
| Mar 31, 2023 | -19.16 Mn |
| Dec 31, 2022 | -15.05 Mn |
API Access
Lexeo Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();